Literature DB >> 12111831

SHP-1 expression in avian mixed neural/glial cultures.

Jeffrey D Sorbel1, Diane M Brooks, Diana I Lurie.   

Abstract

The central nervous system response to injury includes astrocyte proliferation and hypertrophy as well as microglial activation and proliferation. However, not all glial cells enter the cell cycle following damage, and the mechanism that determines which glial cells will proliferate and which will remain quiescent has yet to be elucidated. Protein tyrosine phosphorylation has been shown to play an important role in the regulation of the cell cycle in a number of different systems and has been implicated in both astrocyte proliferation and differentiation. Of particular interest is the protein tyrosine phosphatase SHP-1 (Src homology 2-containing protein tyrosine phosphatase 1), which: (1) modulates cellular proliferation in the hematopoietic system, (2) is involved in various growth factor second messenger signaling cascades, and (3) has been demonstrated by our laboratory to increase in immunoreactivity within a subpopulation of astrocytes following deafferentation of the chicken auditory brainstem. These SHP-1+ cells appear to be those which fail to enter the cell cycle following deafferentation. The present study examines whether manipulation of cellular proliferation in vitro modifies the expression of SHP-1 immunoreactivity in mixed neural/glial cultures of the avian auditory brainstem. In addition, the effect of the protein tyrosine phosphatase inhibitor sodium orthovanadate on cellular proliferation was assessed in these cultures. Our results demonstrate that SHP-1 expression can be modulated by changes in proliferation and that inhibiting tyrosine phosphatase activity results in increased proliferation. Taken together, these results indicate that SHP-1 may play central role in negatively regulating glial proliferation following injury. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111831     DOI: 10.1002/jnr.10262

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Authors:  Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

3.  Impaired stimulatory effect of ETB receptor on D₃ receptor in immortalized renal proximal tubule cells of spontaneously hypertensive rats.

Authors:  Ye Zhang; Chunjiang Fu; Hongmei Ren; Duofen He; Xukai Wang; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Kidney Blood Press Res       Date:  2011-01-11       Impact factor: 2.687

4.  Inhibitory effect of ETB receptor on Na(+)-K(+) ATPase activity by extracellular Ca(2+) entry and Ca(2+) release from the endoplasmic reticulum in renal proximal tubule cells.

Authors:  Yan Liu; Jian Yang; Hongmei Ren; Duofen He; Annabelle Pascua; M Ines Armando; Chengming Yang; Lin Zhou; Robin A Felder; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2009-08-07       Impact factor: 3.872

5.  Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells.

Authors:  Luxun Tang; Shuo Zheng; Hongmei Ren; Duofen He; Chunyu Zeng; Wei Eric Wang
Journal:  Hypertens Res       Date:  2017-02-23       Impact factor: 3.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.